Safety and Immunogenicity Study of the Recombinant Human Papillomavirus Virus Type 6/11 Bivalent Vaccine

Clinical trial NCT02405520 · COMPLETED

Trial details

NCT number: NCT02405520
Sponsor: Jun Zhang
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Condylomata Acuminata

Start date: 2015-03-26
Primary completion: 2019-06-05
Enrollment: 145

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.